Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|
Über diesen Artikel
grade
pharmaceutical primary standard
agency
BP
API family
oxyclozanide
form
liquid (Clear)
shelf life
limited shelf life, expiry date on the label
manufacturer/tradename
BP
mp
209-211 °C (lit.)
application(s)
pharmaceutical
pharmaceutical small molecule
format
neat
storage temp.
2-8°C
SMILES string
OC(=O)c1c(O)c(Cl)cc(Cl)c1Cl
InChI
1S/C7H3Cl3O3/c8-2-1-3(9)6(11)4(5(2)10)7(12)13/h1,11H,(H,12,13)/p-1
InChI key
IIHCUZVBIMTHEB-UHFFFAOYSA-M
General description
Application
Also used in monographs such as:
Packaging
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description British Pharmacopoeia (BP) Reference Standard | description British Pharmacopoeia (BP) Reference Standard | description British Pharmacopoeia (BP) Reference Standard | description British Pharmacopoeia (BP) Reference Standard |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename BP | manufacturer/tradename BP | manufacturer/tradename BP | manufacturer/tradename BP |
| format neat | format neat | format neat | format neat |
| form liquid (Clear) | form solid | form solid | form solid |
| shelf life limited shelf life, expiry date on the label | shelf life limited shelf life, expiry date on the label | shelf life limited shelf life, expiry date on the label | shelf life limited shelf life, expiry date on the label |
| application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical |
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.




